Exhibit 107

Calculation of Filing Fee Table

Form S-8

(Form Type)

Ikena Oncology, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type	Security Class Title	Fee Calculation Rule	Amount Registered (1)	Proposed Maximum Offering Price Per Unit	Maximum Aggregate Offering Price	Fee Rate	Amount of Registration Fee
Equity	Common Stock, $0.001 par value per share	Other (2)	1,450,299 (3)	$4.37	$6,337,806.63	$0.00011020	$698.43
Total Offering Amounts					$6,337,806.63		—
Total Fees Previously Paid							—
Total Fee Offsets							—
Net Fee Due							$698.43

(1) In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions effected without the receipt of consideration which results in an increase in the number of the outstanding shares of the registrant’s common stock, $0.001 par value per share (“Common Stock”).

(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The price per share and aggregate offering price are calculated on the basis of $4.37, the average of the high and low price of the registrant’s Common Stock as reported on the Nasdaq Global Market on March 10, 2023.

(3) Consists of 1,450,299 additional shares issuable under the Registrant’s 2021 Stock Option and Incentive Plan (the “2021 Plan”), which represents the automatic annual increase to the number of shares available for issuance under the 2021 Plan, effective as of January 1, 2023. Shares available for issuance under the 2021 Plan were previously registered on registration statements on Form S-8 (File No. 333-263640) filed with the Securities and Exchange Commission (“SEC”) on March 17, 2022 and Form S-8 (File No. 333-254858) filed with the SEC on March 30, 2021.